ClinConnect ClinConnect Logo
Search / Trial NCT05333380

Study on the Effectiveness of AF Analysis Software in AF Rhythm Monitoring

Launched by BEIJING ANZHEN HOSPITAL · Apr 10, 2022

Trial Information

Current as of August 14, 2025

Unknown status

Keywords

ClinConnect Summary

PPG-AF study is a Cohort randomized observational study.The trial will include patients with AF who meet the study requirements from Beijing Anzhen Hospital within 2 months. Each participant will wear an watch and ECG monitor after admission to hospital until Radiofrequency ablation for AF, and after AF ablation until discharge. And more than 18 hours in each period.

1. Primary endpoint. The ECG and PPG data are automatically analyzed by the AF analysis software. The results are compared with expert-annotated gold standard results to verify the sensitivity and specificity.
2. Secondary end...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Be at least 18 years of age.
  • Have clear ECG-recorded atrial fibrillation in the past and will undergo atrial fibrillation ablation in the current hospitalization.
  • Patients who agree to wear both the watch and the ECG recorder.
  • Exclusion Criteria:
  • Inability to wear the watch due to limited mobility or other problems.
  • Severe skin diseases such as skin allergies or skin ulcers.
  • Chronic insomnia not treated with medication.
  • Patients with severe cardiovascular disease who may be resuscitated at any time.
  • Previous history of Parkinson's, schizophrenia, epilepsy.
  • Black people and those with excessively dark skin.

About Beijing Anzhen Hospital

Beijing Anzhen Hospital is a leading medical institution in China, renowned for its expertise in cardiovascular diseases and comprehensive healthcare services. As a prominent clinical trial sponsor, the hospital is dedicated to advancing medical research and innovation, facilitating the development of new therapies and treatment protocols. With a focus on patient safety and ethical standards, Beijing Anzhen Hospital collaborates with various research entities to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing the understanding of cardiovascular health. Its commitment to excellence in clinical research is underscored by a multidisciplinary team of experienced healthcare professionals and a state-of-the-art facility equipped to support a wide range of clinical investigations.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials